3′-Alkynyl ABA Derivatives as Antagonists for Pulse Crop Germination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Pulse crop production faces challenges such as poor germination under cold and wet conditions, seed dormancy, and increased ABA levels which hinder germination and yield, particularly in lentils and chickpeas, due to the influence of abscisic acid (ABA) levels and signaling pathways.

Innovation Solution

Development of a novel class of 3′-unsaturated ABA derivatives that act as ABA antagonists, reducing adverse effects of ABA responses in plants, thereby promoting germination and overcoming seed dormancy by administering effective amounts of these derivatives to plants.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ABA levels are increased to maintain seed dormancy and protect from abiotic stress, then seed dormancy is maintained and stress protection is improved, but germination is inhibited and yield is reduced

Engineering Contradiction:
Improveseed dormancy maintenanceVSAvoidgermination rate
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent introduces ABA antagonists as intermediary compounds that specifically block ABA signaling pathways without affecting ABA production. These compounds act as mediators between the natural ABA hormone system and the desired germination outcome, allowing dormancy maintenance while preventing ABA-mediated germination inhibition. The antagonists bind to ABA receptors or downstream signaling components, selectively interfering with the harmful signaling while preserving beneficial ABA functions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent modifies the physiological parameter of ABA signaling sensitivity by introducing exogenous ABA antagonists. This changes the effective concentration-response relationship of ABA in the seed, allowing the system to maintain dormancy at normal ABA levels while becoming resistant to ABA-induced germination inhibition. The parameter change is achieved through competitive binding or signaling pathway interference rather than altering ABA production or degradation rates.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If ABA levels are increased to protect plants from abiotic stress, then stress tolerance is improved, but germination under suboptimal conditions is inhibited

Engineering Contradiction:
Improveabiotic stress protectionVSAvoidgermination under cold and wet conditions
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The ABA antagonists serve as selective intermediaries that distinguish between beneficial ABA signaling (stress protection) and harmful ABA signaling (germination inhibition). By targeting specific ABA receptors or signaling components involved in germination control, the antagonists allow stress-responsive ABA pathways to remain functional while blocking germination-inhibiting signals, even under cold and wet suboptimal conditions.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

Instead of trying to reduce ABA levels to promote germination (which would compromise stress protection), the patent inverts the approach by maintaining or even increasing ABA levels while introducing antagonists that specifically counteract the harmful germination-inhibiting effects. This inversion allows the system to benefit from high ABA stress protection while avoiding germination inhibition through selective signaling blockade.

Inventive Principle:
Principle #13The other way round (Inversion)

3Reliability

If ABA signaling is enhanced to maintain dormancy, then dormancy maintenance is improved, but crop establishment and yield are reduced

Engineering Contradiction:
Improvedormancy maintenanceVSAvoidcrop establishment
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent employs ABA antagonists as selective intermediaries that can be applied at specific developmental stages to modulate ABA signaling. During the establishment phase, the antagonists act as mediators to block ABA-mediated germination inhibition and promote uniform crop emergence, while allowing dormancy maintenance to proceed naturally in seeds that require it. This staged intervention resolves the contradiction between dormancy maintenance and crop establishment.

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS12063929B23′-alkynyl abscisic acid derivatives as ABA antagonists
Publication Date: 2024.08.20 UNIVERSITY OF SASKATCHEWAN
  • US12063929B2 patent drawing
  • US12063929B2 patent drawing
  • US12063929B2 patent drawing

AI summary

The present application relates to novel 3′-unsaturated abscisic acid (ABA) derivatives of Formula (I) as ABA antagonists. For example, the present application relates to methods of using compounds of Formula (I) for reducing adverse effects of an ABA response in plants such as lentil and promoting germination. (I) The present application also relates to methods of using 3′-phenyl abscisic acid (ABA) derivatives of Formula (II) as ABA antagonists, for example, for reducing adverse effects of an ABA response in plants such as lentil and promoting germination. (II)